WAKEFIELD, Mass.--(BUSINESS WIRE)--One of the biggest challenges in drug development and personalized medicine is how to model the cellular microenvironment accurately. The challenge applies to both ...
SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback